Jacobs Levy Equity Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
123,482
-233,766
| -65% | -$2.65M | 0.01% | 691 |
|
|
2025
Q1 | $2.38M | Buy |
+357,248
| New | +$2.38M | 0.01% | 619 |
|
|
2024
Q3 | – | Sell |
-46,059
| Closed | -$622K | – | 1042 |
|
|
2024
Q2 | $622K | Sell |
46,059
-1,853
| -4% | -$25K | ﹤0.01% | 813 |
|
|
2024
Q1 | $647K | Sell |
47,912
-120,116
| -71% | -$1.62M | ﹤0.01% | 785 |
|
|
2023
Q4 | $884K | Sell |
168,028
-49,577
| -23% | -$261K | ﹤0.01% | 744 |
|
|
2023
Q3 | $857K | Buy |
+217,605
| New | +$857K | 0.01% | 700 |
|
|
2022
Q1 | – | Sell |
-22,480
| Closed | -$539K | – | 1084 |
|
|
2021
Q4 | $539K | Buy |
+22,480
| New | +$539K | ﹤0.01% | 824 |
|
|
2020
Q4 | – | Sell |
-6,683
| Closed | -$224K | – | 1094 |
|
|
2020
Q3 | $224K | Buy |
+6,683
| New | +$224K | ﹤0.01% | 942 |
|